I-Tofacitnib Citrate

Incazelo emfushane:

Igama le-API Inkomba Ukucaciswa I-US DMF I-EU DMF CEP
I-Tofacitnib Citrate I-Rheumatoid arthritis Endlini      


Imininingwane Yomkhiqizo

Omaka bomkhiqizo

IMINININGWANE YOMKHIQIZO

Ingemuva

I-Tofacitinib citrate, eyaziwa nangokuthi i-CP-690550 citrate, iyi-inhibitor enamandla ye-janus kinase 3 (JAK3), i-tyrosine kinase ekhawulelwe ngamaseli e-hematopoetic ehilelekile ekudlulisweni kwesignali elawula ukusinda kwe-lymphocyte, ukwanda, ukuhlukaniswa, kanye ne-apoptosis.Ukuvinjelwa kucaciswe nge-JAK3 ngokukhetha okuphindwe ka-1000 ngaphezu kwamanye ama-kinase omndeni angewona ama-JAK.Ngaphandle kokuvimbela i-JAKS (IC50 = 1 nM), i-tofacitinib citrate iphinde ivimbele i-janus kinase 2 (JAK2) kanye ne-janus kinase 1 (JAK1) enamandla angu-20- kanye ne-100 ngokulandelana.Nokho, ocwaningweni lwakamuva, izibopho ezibophezelayo (Ki) ze-tofacitinib citrate eziya ku-JAK1, JAK2, ne-JAK3 kubikwe ukuthi ziyi-1.6 nM, 21.7 nM, kanye ne-6.5 nM ngokulandelanayo.

Ireferensi

Lalitha Vijayakrishnan, R. Venkataramanan and Palak Gulati.Ukwelapha ukuvuvukala nge-janus kinase inhibitor CP-690,550.Amathrendi ku-Pharmacological Science 2011: 32 (1);25-34

Ukucaphuna Komkhiqizo

  • 1. Panagi I, Jennings E, et al."I-Salmonella Effector SteE Iguqula i-Mammalian Serine/Threonine Kinase GSK3 ibe i-Tyrosine Kinase ukuze Iqondise I-Macrophage Polarization."I-Cell Host Microbe.2020;27(1):41–53.e6.PMID:31862381
  • 2. McInnes IB, Byers NL, et al."Ukuqhathaniswa kwe-baricitinib, upadacitinib, kanye ne-tofacitinib mediated regulation of cytokine signing in human leukocyte subpopulations."I-Arthritis Res Ther.2019 Aug 2;21(1):183.PMID:31375130
  • 3. U-Liu S, u-Verma M, nabanye."Ukuphikiswa kwe-Steroid kohlobo 2 lwamaseli e-lymphoid angaphakathi avela ezigulini ezine-asthma enzima: Indima ye-thymic stromal lymphopoietin." J Allergy Clin Immunol.2018 Jan;141(1):257-268.e6.PMID:28433687
  • 4. UZheng, uLufeng, nabanye."I-3′ UTR ye-pseudogene CYP4Z2P ikhuthaza i-tumor angiogenesis kumdlavuza webele ngokusebenza njenge-ceRNA ye-CYP4Z1."Ucwaningo nokwelashwa komdlavuza webele (2015): 1-14.PMID:25701119

Incazelo

I-Tofacitinib citrate iyisivimbeli esitholakala ngomlomo se-JAK1/2/3 esinama-IC50s angu-1, 20, kanye no-112 nM, ngokulandelana.I-Tofacitinib citrate ine-antibacterial, antifungal kanye nemisebenzi ye-antiviral.

Isitoreji

4°C, vikela ekukhanyeni

*Ku-solvent : -80°C, izinyanga ezingu-6;-20°C, inyanga engu-1 (vikela ekukhanyeni)

 

Isakhiwo samakhemikhali

Tofacitnib Citrate

Idatha Yebhayoloji Ehlobene

Tofacitnib Citrate2

Idatha Yebhayoloji Ehlobene

Tofacitnib Citrate3

Idatha Yebhayoloji Ehlobene

Tofacitnib Citrate4

Idatha Yebhayoloji Ehlobene

Tofacitnib Citrate5

Idatha Yebhayoloji Ehlobene

Tofacitnib Citrate6

ISItifiketi

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

UKUPHATHWA KWEKHWALITHI

Quality management1

Isiphakamiso18Amaphrojekthi Wokuhlola Ukuvumelana Kwekhwalithi asegunyaziwe4, futhi6amaphrojekthi angaphansi kokugunyazwa.

Quality management2

Uhlelo lokuphatha ikhwalithi yamazwe ngamazwe oluthuthukile lwenze isisekelo esiqinile sokuthengisa.

Quality management3

Ukugadwa kwekhwalithi kusebenza kuwo wonke umjikelezo wempilo womkhiqizo ukuze kuqinisekiswe ikhwalithi nomphumela wokwelapha.

Quality management4

Ithimba Lezindaba Zokulawula Ochwepheshe lisekela izimfuno zekhwalithi ngesikhathi sokufaka isicelo nokubhaliswa.

UKUPHATHWA KOMKHIQIZO

cpf5
cpf6

I-Korea Countec Bottled Packaging Line

cpf7
cpf8

I-Taiwan CVC Bottled Packaging Line

cpf9
cpf10

I-Italy CAM Board Packaging Line

cpf11

Umshini Wokuhlanganisa we-Fette waseJalimane

cpf12

I-Japan Viswill Tablet Detector

cpf14-1

I-DCS Control Room

UZAkwethu

Ukubambisana kwamazwe ngamazwe
International cooperation
Ukubambisana kwasekhaya
Domestic cooperation

  • Okwedlule:
  • Olandelayo:

  • Bhala umlayezo wakho lapha futhi usithumelele wona